Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: The Drakenstein Child Health Study

The Lancet Global Health

Volumn 3, Issue 2, 2015, Pages e95-e103

  Le Roux, David M ^a   Myer, Landon ^b   Nicol, Mark P ^c   Zar, Heather J ^a  

^a RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

AGE; ARTICLE; CHILD DEATH; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; EMPYEMA; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MATERNAL SMOKING; PNEUMONIA; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RISK FACTOR; SEPTICEMIA; SOUTH AFRICAN; STUNTING; TACHYPNEA; NEWBORN; POISSON DISTRIBUTION; SOUTH AFRICA;

FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA; POISSON DISTRIBUTION; RISK FACTORS; SOUTH AFRICA; VACCINES, CONJUGATE;

EID: 84921358196     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70360-2     Document Type: Article

References (46)

1. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
2. Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384:957-979.
3. Fischer Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013, 381:1405-1416.
4. Edmond K, Scott S, Korczak V, et al. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PloS One 2012, 7:e31239.
5. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 2004, 82:895-903.
6. Rudan I, O'Brien KL, Nair H, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 2013, 3:10401.
7. Black S, Shinefield H Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California. Eur J Pediatr 2002, 161(suppl 2):S127-S131.
8. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365:1139-1146.
9. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003, 349:1341-1348.
10. Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev 2009, 4. CD004977.
11. O'Brien KL, Moulton LH, Reid R, et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 2003, 362:355-361.
12. De Wals P, Lefebvre B, Defay F, Deceuninck G, Boulianne N Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada. Vaccine 2012, 30:6416-6420.
13. Durando P, Crovari P, Ansaldi F, et al. Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine 2009, 27:3459-3462.
14. Grijalva CG, Griffin MR Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Expert Rev Vaccines 2008, 7:83-95.
15. Simonsen L, Taylor RJ, Schuck-Paim C, Lustig R, Haber M, Klugman KP Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. Lancet Respir Med 2014, 2:387-394.
16. Pirez MC, Algorta G, Chamorro F, et al. Changes in Hospitalizations for Pneumonia After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13 Valent and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J 2014, 33:753-759.
17. Afonso ET, Minamisava R, Bierrenbach AL, et al. Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil. Emerg Infect Dis 2013, 19:589-597.
18. Madhi SA, Cohen C, von Gottberg A Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine 2012, 30(suppl 3):C21-C27.
19. Zar HJ, Barnett W, Myer L, Stein DJ, Nicol MP Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study. Thorax 2014, published online Sept 16. 10.1136/thoraxjnl-2014-206242.
20. Integrated management of childhood illness: distance learning course 2014, WHO, WHO, Geneva.
21. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatrica 2006, 450:76-85. WHO.
22. Gentile A, Bardach A, Ciapponi A, et al. Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Infect Dis 2012, 16:e5-15.
23. Madhi SA, De Wals P, Grijalva CG, et al. The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J 2013, 32:e119-e127.
24. Ásbjörnsdóttir KH, Slyker JA, Weiss NS, et al. Breastfeeding is associated with decreased pneumonia incidence among HIV-exposed, uninfected Kenyan infants. AIDS 2013, 27:2809-2815.
25. Becker-Dreps S, Amaya E, Liu L, et al. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. Pediatr Infect Dis J 2014, 33:637-642.
26. Gurley ES, Homaira N, Salje H, et al. Indoor exposure to particulate matter and the incidence of acute lower respiratory infections among children: a birth cohort study in urban Bangladesh. Indoor air 2013, 23:379-389.
27. Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG Invasive pneumococcal infections among vaccinated children in the United States. J Pediatr 2010, 156:478. 83.e2.
28. Ruckinger S, van der Linden M, von Kries R Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants. BMC Infect Dis 2010, 10:12.
29. Cohen C, von Mollendorf C, de Gouveia L, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine (PCV-7) against invasive pneumococcal disease in HIV-infected and -uninfected children in South Africa: a matched case-control study. Clin Infect Dis 2014, 59:808-818.
30. Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J 2014, 33(suppl 2):S140-S151.
31. Reikie BA, Adams RC, Leligdowicz A, et al. Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr 2014, 66:245-255.
32. Kidzeru EB, Hesseling AC, Passmore JA, et al. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS 2014, 28:1421-1430.
33. Casimir GJ, Mulier S, Hanssens L, Zylberberg K, Duchateau J Gender differences in inflammatory markers in children. Shock 2010, 33:258-262.
34. Garenne M Sex differences in health indicators among children in African DHS surveys. J Biosoc Sci 2003, 35:601-614.
35. Martinez FD, Antognoni G, Macri F, et al. Parental smoking enhances bronchial responsiveness in nine-year-old children. Am Rev Respir Dis 1988, 138:518-523.
36. Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996, 348:1060-1064.
37. Zar HJ, Ferkol TW The global burden of respiratory disease-impact on child health. Pediatr Pulmonol 2014, 49:430-434.
38. Bhutta ZA, Das JK, Walker N, et al. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?. Lancet 2013, 381:1417-1429.
39. Tylleskar T, Jackson D, Meda N, et al. Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trial. Lancet 2011, 378:420-427.
40. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008, 86:408-416.
41. Chisti MJ, Tebruegge M, La Vincente S, Graham SM, Duke T Pneumonia in severely malnourished children in developing countries-mortality risk, aetiology and validity of WHO clinical signs: a systematic review. Trop Med Int Health 2009, 14:1173-1189.
42. Berkley JA, Munywoki P, Ngama M, et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 2010, 303:2051-2057.
43. Reed C, Madhi SA, Klugman KP, et al. Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa. PloS One 2012, 7:e27793.
44. Zar HJ, Hanslo D, Tannenbaum E, et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr 2001, 90:119-125.
45. Gowraiah V, Awasthi S, Kapoor R, et al. Can we distinguish pneumonia from wheezy diseases in tachypnoeic children under low-resource conditions? A prospective observational study in four Indian hospitals. Arch Dis Child 2014, 99:899-906.
46. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.